Delivery Order SPE2DB22D3010-SPE2DB26FP0VL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,091.46. This is a non-set-aside competitive award with an ultimate completion date of September 23, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents pharmaceutical procurement to support federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Januvia 100 mg tablets (90-count) valued at $5,106.30 under a firm fixed price arrangement. This non-set-aside delivery order is due for completion by October 23, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award represents a competitive procurement action that leverages AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,455.28. The award, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the performing location for this delivery order, which falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, effective through May 30, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $2,182.92. This competitively awarded, non-set-aside delivery order is scheduled for completion by October 24, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Januvia 100 mg tablets (90-count) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by September 16, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed price contract type. The award was made on October 20, 2025, with an ultimate completion date of October 21, 2025, and reflects a competitively awarded, non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $2,105.91. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this award. No set-aside designation was used in this competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $1,718.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item purchase under AmerisourceBergen's existing pharmaceutical supply relationship...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB26FP0VLDelivery Order
The Defense Logistics Agency awarded a competitively bid delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $16,310.52. This firm fixed-price delivery order, effective through November 5, 2025, represents a continuation of the prime contractor's role as a critical pharmaceutical supplier within the federal medical supply chain. The award was issued under a non-set-aside competitive procurement process and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen holds a significant position within the DLA's Medical Supply Chain and continues to support federal procurement requirements through competitively awarded contracts spanning multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 11/4/25 |